Furthermore, the postoperative inflammatory response contributing to platelet count reduction and the platelet activation indicated by biomarker expression (CD62P-CD36) were correlated with the volume of new-onset thrombus in AAA with AAA volume.13,14) Hence, platelet abundance and function rather than hemostatic factors appear to be more sensitive biomarkers for EVAR success and AAA prognosis. This evidence concerns the gene CD36 and triple-A syndrome.